Sale by Peter Rahmer (Chief Corporate Development Officer)
753 shares · @ $14.79 · $11,137
Relay Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $14.26
-1.9% in 1d after detection
Post-detection moves
1h
—
1d
-1.9%
3d
+0.3%
7d
-0.8%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS